Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.Unknown journal · 2025-11-06Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.Unknown journal · 2025-10-22Biological markers of treatment response to serotonergic psychedelic therapies: a systematic review.Unknown journal · 2025-10-15Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532].Unknown journal · 2025-10-09Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.Unknown journal · 2025-09-06Mapping psilocybin therapy: A systematic review of therapeutic frameworks, adaptations, and standardization across contemporary clinical trials.Unknown journal · 2025-07-17Non-hallucinogenic psychedelics for mood and anxiety disorders: A systematic review.Unknown journal · 2025-05-07Pharmacokinetics of Psilocybin: A Systematic Review.Unknown journal · 2025-03-24Psychedelics and Suicide-Related Outcomes: A Systematic Review.Unknown journal · 2025-02-19Psilocybin-assisted therapy for depression: A systematic review and meta-analysis.Unknown journal · 2023-10-10Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.Unknown journal · 2023-08-23Antidepressant Effects of Psilocybin in the Absence of Psychedelic Effects.Unknown journal · 2023-03-21Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression.New England Journal of Medicine · 2022-10-31A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.Unknown journal · 2022-10-02The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.Unknown journal · 2022-08-16Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits?Expert opinion on drug safety · 2022-05-31Serotonergic psychedelics for depression: What do we know about neurobiological mechanisms of action?Frontiers in psychiatry · 2021-12-31